HealthUtah Approves AI Chatbots to Refill Psychiatric Meds: Risks and Benefits ExploredAI system can now prescribe psychiatric drugs in Utah, raising concerns about transparency and access. Explore the potential impact on mental health care costs and shortages.22 days ago120
HealthStroke Survivors Struggle with Inadequate NHS Rehab CareNHS faces critical shortage of rehabilitation staff, limiting recovery chances for stroke patients, warn health leaders.22 days ago140
HealthProsecutors Weigh 13 Assisted Dying Cases in England and WalesLatest data reveals 209 suspected assisted dying cases referred to prosecutors in England and Wales over the past year, with 13 currently under consideration.23 days ago150
HealthUK-US Medicine Deal: Tariff Exemption, But NHS Cost ConcernsBritish drug exports to the US will be tariff-free, but critics argue the 'partnership' on drug pricing could cost the NHS billions.23 days ago220
HealthBringing Joy and Hope to Young Patients in Tehran's Children's HospitalDiscover how the dedicated staff at the Children's Medical Center in Tehran are going above and beyond to provide a positive and uplifting experience for children during wartime.23 days ago140
HealthPresident Raises Awareness on Autism's Profound ImpactOn Autism Awareness Day, the President acknowledges the challenges faced by the autism community and pledges continued support.23 days ago150
HealthResident Doctors' Strike Looms as Talks Collapse: NHS Braces for Longest Walkout YetWes Streeting accuses medics of 'delusion' as six-day stoppage in England set to begin, with training place offer withdrawn.23 days ago190
HealthUK-US Forge Closer Ties on Medical Device Regulations for Faster InnovationsThe UK and US regulators are enhancing cooperation on medical device oversight to accelerate safe, cutting-edge technologies for patients. This expands their existing pharmaceutical partnership.23 days ago150
HealthRevolutionizing Medicines Access: Historic UK-US Pharma Partnership Unlocks BenefitsGroundbreaking deal boosts NHS patient access to new drugs, while attracting increased life sciences investment into the UK. Discover the transformative impact of this historic pharmaceutical partnership.23 days ago120
HealthAI's Struggle to Crack Depression Detection: The Kintsugi ShutdownKintsugi, a startup developing AI for depression detection, is shutting down after failing to secure FDA clearance. The challenges highlight the hurdles in bringing AI-powered mental health tools to market.23 days ago120
